Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Locally Advanced Prostate Cancer × Cisplatin × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 101 Carcinoma, Transitional Cell 35 Urethral Neoplasms 17 Testicular Neoplasms 17 Ovarian Neoplasms 11 Prostatic Neoplasms 10 Testicular Germ Cell Tumor 9 Melanoma 8 Carcinoma, Non-Small-Cell Lung 8 Ureteral Neoplasms 7 Teratoma 7 Seminoma 7 Neoplasms 7 Endodermal Sinus Tumor 7 Stomach Neoplasms 6 Penile Neoplasms 6 Neoplasm Metastasis 6 Colorectal Neoplasms 6 Carcinoma, Renal Cell 6 Breast Neoplasms 6 Sarcoma 5 Pancreatic Neoplasms 5 Carcinoma, Embryonal 5 Urothelial Cancer 4 Lung Neoplasms 4 Wilms Tumor 3 Uterine Cervical Neoplasms 3 Triple Negative Breast Neoplasms 3 Teratoma, Testicular 3 Squamous Cell Carcinoma of Head and Neck 3

Interventions

tislelizumab 1 pamiparib 1 TNFeraseBiologic 1 Injections 1 Gefitinib 1 Docetaxel 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06387056 2024-04-26

SEGNO

The First Affiliated Hospital of Xiamen University

Phase 2 Recruiting

Locally Advanced Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡